AI TOOL PROFILE
vcreate: T-cell Receptor Engineering Platform
- Healthcare
- Biotechnology Platform
- Biotechnology companies
- Pharmaceutical companies
- Research labs
Pricing
Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
At a glance
- Best for
- Biotechnology companies, Pharmaceutical companies, Research labs
- Key use cases
- TCR-Based Drug Discovery, Cancer Mutation Targeting, Lead Identification
- Official website
- Visit vcreate official website
How AI is used
vcreate is a biotechnology platform designed to engineer human T-cell receptors (TCRs) for treating diseases, specifically focusing on cancer. The platform uses machine learning and molecular biology to identify TCRs that target disease-specific mutations, including those that are difficult to address with conventional therapies.
The tool is intended for use by biotechnology companies, pharmaceutical firms, and research laboratories. By using single-cell sequencing, the platform can screen hundreds of millions of interactions in a single experiment, which is designed to support faster discovery compared to traditional methods like yeast display or tetramer staining.
Buyers should note that the platform focuses specifically on TCR-based drug design. Interested parties should contact the company directly to discuss collaboration or co-development options.
Key Features
Machine Learning Design
Algorithms trained on datasets to design T-cell receptors that activate against specific targets of interest.
High-Throughput Screening
Screening assays that can interrogate hundreds of millions of TCR-antigen interactions in a single flask.
Single-Cell Sequencing
Use of single-cell sequencing to support the identification of TCRs for disease-specific targets.
Rare Mutation Targeting
Designed to target rare cancer mutations even when they are not present in experimental datasets.
Use Cases
TCR-Based Drug Discovery
Designing high-precision T-cell receptors intended to destroy target cells while sparing normal cells.
Cancer Mutation Targeting
Identifying TCRs that can guide the immune system to eliminate cells carrying specific mutated genes.
Lead Identification
Using high-speed screening to identify receptors that activate against disease targets.
FAQ
What does vcreate do?
- vcreate uses machine learning and molecular biology to design and engineer human T-cell receptors (TCRs) used in the treatment of diseases such as cancer.
Who is vcreate designed for?
- The platform is designed for biotechnology companies, pharmaceutical companies, and research laboratories focusing on TCR-based therapies.
How does vcreate support the discovery process?
- By using single-cell sequencing and novel assays, the platform can screen hundreds of millions of TCR-antigen interactions in a single experiment.
Source category: Healthcare
Source subcategory: Biotechnology Platform
More tools in Healthcare
Other published listings in the Healthcare category.
